Tag Archives: Quantitative NfL Assays

Fujirebio and H.U. Group Holdings Launch Quantitative NfL Assays for Research Use Only

Posted on 29, March 2023 by EuropaWire PR Editor

(IN BRIEF) H.U. Group Holdings Inc. and Fujirebio have announced the launch of Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE G immunoassay systems. These assays can quantitatively measure Neurofilament light (NfL) … Read the full press release →

Posted in Belgium, Education, Healthcare, Management, News, Science, Technology

Tagged Alzheimer’s disease, Belgium, Christiaan De Wilde, CLEIA, Fujirebio, H.U. Group Holdings, human cerebrospinal fluid (CSF), LUMIPULSE G immunoassay systems, Lumipulse G NfL Blood assays, Lumipulse G NfL CSF, multiple sclerosis, Neurofilament light (NfL), Parkinson disease, plasma/serum, Quantitative NfL Assays, Research Use Only